Presented at the AMP 2022 Annual Meeting, this presentation provides an analytical performance of Thermo Fisher Scientific’s Oncomine Precision Assay on the Genexus System at two of our global...
Presentation by Joanne Hackett, Head of Genomic and Precision Medicine, IQVIA and David Latto, Associate Director, Science Liaison, Q2 SolutionsJoanne and David provide an overview of IQVIA and Q2...
Although reference samples with known ground truth regarding variants have been around for a while (NIST genome-in-a-bottle samples, HapMap samples, etc.), none have variants in large number...
In this presentation, Q2 Solutions and Illumina discuss key strategies for European oncology clinical trials and the benefits of a global laboratory network for genomic biomarker testing. You will...
Advances in sequencing technologies are allowing clinical and translational researchers to gain deeper insights into disease biology and treatment response mechanisms. However, the impact of existing...